RESUMO
BACKGROUND: Neuroblastoma accounts for 15 % of cancer deaths in children. Complete surgical resection is associated with a higher overall survival rate but also a higher morbidity rate. An international group of experts has defined a nomenclature of image-defined risk factors (IDRFs) for the determination of operability and the anticipation of reasonably foreseeable complications of surgery. However, there is no consensus on the optimal imaging modality (CT or MRI) for the assessment of IDRFs. The objective of the present study was to determine the non-inferiority of MRI vs. CT in the preoperative assessment of abdominopelvic neuroblastoma. The secondary objective was to assess the contribution of gadolinium contrast enhancement. METHODS: All children diagnosed with abdominopelvic neuroblastoma and whose preoperative work-up included a contrast-enhanced CT or MRI scan of the abdomen and pelvis between January 2014 and January 2023 were included. To evaluate the IDRFs, all the images were reviewed in three steps: (i) non-contrast MRI scans, (ii) both non-contrast and contrast-enhanced MRI scans, and (iii) contrast-enhanced CT scans. RESULTS: Twenty-five patients were found to be eligible, and fifteen were included. The mean time interval between MRI and preoperative CT was 23 days. In all patients, the identified IDRFs were similar for all three imaging modalities. Fourteen patients underwent full resection of the tumour. The surgical reports were fully consistent with the IDRFs described on CT and/or MRI. CONCLUSION: A high-resolution three-dimensional T2 MRI sequence agreed fully with contrast-enhanced CT for the detection of IDRFs. Contrast-enhanced MRI did not add value. However, surgeons will need time to adapt to this MRI-based approach and learn how to interpret the results with confidence.
Assuntos
Neoplasias Abdominais , Meios de Contraste , Imageamento por Ressonância Magnética , Estadiamento de Neoplasias , Neuroblastoma , Cuidados Pré-Operatórios , Tomografia Computadorizada por Raios X , Humanos , Neuroblastoma/diagnóstico por imagem , Neuroblastoma/cirurgia , Neuroblastoma/patologia , Imageamento por Ressonância Magnética/métodos , Feminino , Masculino , Pré-Escolar , Tomografia Computadorizada por Raios X/métodos , Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/cirurgia , Lactente , Cuidados Pré-Operatórios/métodos , Fatores de Risco , Criança , Medição de Risco , Neoplasias Pélvicas/diagnóstico por imagem , Estudos RetrospectivosRESUMO
OBJECTIVE: This study aimed to estimate the performance of single-phase-enhanced computed tomography and ultrasonography examinations in the preoperative evaluation of solid abdominal tumors and their relationship with relevant adjacent structures in children. METHODS: This retrospective study included 50 pediatric patients with malignant solid abdominal tumors treated with surgical resection between 2009-2017. Preoperative computed tomography and ultrasonography were compared to operative findings (gold standard) in the diagnosis of invasion or encasement of adjacent structures. Accuracy, sensitivity, specificity, and positive and negative predictive values were evaluated. RESULTS: Renal (20.4%) and neuroblastic (19.4%) tumors were the most common. Complete surgical resection with negative margins was achieved in 44 (88%) patients. The comparison between single-phase-enhanced computed tomography and ultrasonography findings showed the following results: sensitivity = 90.3% vs 86.6%, specificity = 86.8% vs 94.6%, negative predictive value = 95.3% vs 94.4%, positive predictive value = 75.3% vs 86.9%, and accuracy = 87.9% vs 92.2%. The correlation (kappa index) between computed tomography and ultrasonography examinations was 0.72 (p < 0.001). In 14% (7/50) of the patients, the invasion of adjacent structures was diagnosed by ultrasonography but not by computed tomography (1 patient had 2 invaded structures). CONCLUSION: Ultrasonography can be considered a complementary method to single-phase-enhanced computed tomography in the preoperative evaluation of children with an abdominal tumor. The present study showed that ultrasonography and single-phase-enhanced computed tomography each possess a high accuracy in the preoperative planning of resection of solid abdominal tumors in children. Thus, it seems that the combination of both imaging methods would be enough for the evaluation of most abdominal tumors in the pediatric population.
Assuntos
Neoplasias Abdominais , Tomografia Computadorizada por Raios X , Humanos , Criança , Estudos Retrospectivos , Sensibilidade e Especificidade , Ultrassonografia , Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/cirurgiaRESUMO
We present a robust deep learning-based framework for dose calculations of abdominal tumours in a 1.5 T MRI radiotherapy system. For a set of patient plans, a convolutional neural network is trained on the dose of individual multi-leaf-collimator segments following the DeepDose framework. It can then be used to predict the dose distribution per segment for a set of patient anatomies. The network was trained using data from three anatomical sites of the abdomen: prostate, rectal and oligometastatic tumours. A total of 216 patient fractions were used, previously treated in our clinic with fixed-beam IMRT using the Elekta MR-linac. For the purpose of training, 176 fractions were used with random gantry angles assigned to each segment, while 20 fractions were used for the validation of the network. The ground truth data were calculated with a Monte Carlo dose engine at 1% statistical uncertainty per segment. For a total of 20 independent abdominal test fractions with the clinical angles, the network was able to accurately predict the dose distributions, achieving 99.4% ± 0.6% for the whole plan prediction at the 3%/3 mm gamma test. The average dose difference and standard deviation per segment was 0.3% ± 0.7%. Additional dose prediction on one cervical and one pancreatic case yielded high dose agreement of 99.9% and 99.8% respectively for the 3%/3 mm criterion. Overall, we show that our deep learning-based dose engine calculates highly accurate dose distributions for a variety of abdominal tumour sites treated on the MR-linac, in terms of performance and generality.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/radioterapia , Aprendizado Profundo , Imageamento por Ressonância Magnética/métodos , Redes Neurais de Computação , Aceleradores de Partículas , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador/instrumentação , Planejamento da Radioterapia Assistida por Computador/métodos , Radioterapia de Intensidade Modulada/métodos , Humanos , Masculino , Método de Monte Carlo , Metástase Neoplásica , Neoplasias da Próstata/diagnóstico por imagem , Neoplasias da Próstata/radioterapia , Neoplasias Retais/diagnóstico por imagem , Neoplasias Retais/tratamento farmacológico , Reprodutibilidade dos TestesRESUMO
PURPOSE: To evaluate PET/MR lung nodule detection compared to PET/CT or CT, to determine growth of nodules missed by PET/MR, and to investigate the impact of missed nodules on clinical management in primary abdominal malignancies. METHODS: This retrospective IRB-approved study included [18F]-FDG PET/MR in 126 patients. All had standard of care chest imaging (SCI) with diagnostic chest CT or PET/CT within 6 weeks of PET/MR that served as standard of reference. Two radiologists assessed lung nodules (size, location, consistency, position, and [18F]-FDG avidity) on SCI and PET/MR. A side-by-side analysis of nodules on SCI and PET/MR was performed. The nodules missed on PET/MR were assessed on follow-up SCI to ascertain their growth (≥ 2 mm); their impact on management was also investigated. RESULTS: A total of 505 nodules (mean 4 mm, range 1-23 mm) were detected by SCI in 89/126 patients (66M:60F, mean age 60 years). PET/MR detected 61 nodules for a sensitivity of 28.1% for patient and 12.1% for nodule, with higher sensitivity for > 7 mm nodules (< 30% and > 70% respectively, p < 0.05). 75/337 (22.3%) of the nodules missed on PET/MR (follow-up mean 736 days) demonstrated growth. In patients positive for nodules at SCI and negative at PET/MR, missed nodules did not influence patients' management. CONCLUSIONS: Sensitivity of lung nodule detection on PET/MR is affected by nodule size and is lower than SCI. 22.3% of missed nodules increased on follow-up likely representing metastases. Although this did not impact clinical management in study group with primary abdominal malignancy, largely composed of extra-thoracic advanced stage cancers, with possible different implications in patients without extra-thoracic spread.
Assuntos
Neoplasias Abdominais , Neoplasias Pulmonares , Neoplasias Abdominais/diagnóstico por imagem , Fluordesoxiglucose F18 , Humanos , Pulmão , Neoplasias Pulmonares/diagnóstico por imagem , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Estudos Retrospectivos , Sensibilidade e Especificidade , Tomografia Computadorizada por Raios XRESUMO
To assess the accuracy of prenatal diagnosis and the prognosis of fetal-abdominal masses, we reviewed all of the cases which had been diagnosed as having abdominal masses from January 2014 to December 2016. In total, 264 cases were identified as having abdominal masses. Among them, 141 cases (53%) had received specific prenatal diagnoses by prenatal ultrasound (US). MRI had assisted in the diagnosis and prognostic evaluation in 69 cases, increasing the diagnostic rate to 65%. The prenatal diagnoses of 111 cases (65%) were concordant with the postnatal diagnoses. Surgical intervention after birth was needed in 96 cases (39%). Most outcomes were good (89%). We suggest that prenatal US can detect and identify most fetal abdominal masses and that MRI helps to further describe the masses. With early intervention after birth, the prognosis was good in most cases. Impact Statement What is already known on this subject? Fetal-abdominal masses are commonly detected in antenatal examinations. A prenatal ultrasound is the main screening tool for detecting fetal intra-abdominal cystic lesions. What the results of this study add? We suggest that MRI is more helpful in some systems to reveal locations and structures. Even prenatal diagnosis cannot reach before birth, prognosis is quite good and expectant therapy is sufficient. What the implications are of these findings for clinical practice and/or future research? Our data strengthens the current knowledge of fetal abdominal masses to help relieve anxious parents by telling them that this congenital malformation has good outcomes. But multidiscipline consultation is necessary.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Cistos/diagnóstico por imagem , Doenças Fetais/diagnóstico por imagem , Imageamento por Ressonância Magnética/estatística & dados numéricos , Ultrassonografia Pré-Natal/estatística & dados numéricos , Adulto , Feminino , Humanos , Gravidez , Estudos Retrospectivos , Adulto JovemRESUMO
The added value and strength of dual energy computed tomography for the evaluation of oncologic patients revolve around the use of lower energy reconstructed images and iodine material density images. Lower keV simulated monoenergetic images optimize soft tissue tumor to nontumoral attenuation differences and increase contrast to noise ratios to improve lesion detection. Iodine material density images or maps are helpful from a qualitative standpoint for image interpretation because they result in improved detection and characterization of tumors and lymph node involvement, and from a quantitative assessment by enabling interrogation of specific properties of tissues to predict and assess therapeutic response.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Imagem Radiográfica a Partir de Emissão de Duplo Fóton/métodos , Tomografia Computadorizada por Raios X/métodos , Abdome/diagnóstico por imagem , HumanosRESUMO
Widespread use of fluorodeoxyglucose-positron emission tomography (PET) in cancer imaging may result in a number of indeterminate and false-positive findings. We investigated the role of contrast-enhanced ultrasound (CEUS) as a second-level option after inconclusive PET. We reviewed CEUS images acquired over 4 y, selecting the examinations performed specifically to better assess an unclear PET image. Final diagnosis was confirmed by biopsy, surgery, further imaging or follow-up. Seventy CEUS examinations were performed after a PET scan (44 PET examinations, 19 PET-computer tomography [CT] examinations and 7 PET-CECT examinations). The target organ was the liver in 54 cases, spleen in 12, gallbladder in 2 and pancreas and kidney in one each. In 6 of 70 cases, CEUS was performed because of a negative PET (no uptake) despite an abnormal finding on the CT images of the PET-CT study; CEUS allowed a correct diagnosis in all of these. In 20 of 70 cases, the PET findings were categorized as indeterminate and non-specific (non-specific fluorodeoxyglucose uptake in PET report with no standardized uptake value given); CEUS reached a correct diagnosis in 19 of the 20 cases with one false negative. In 34 of 70 cases, PET was indeterminate, but specific (fluorodeoxyglucose uptake with a standardized uptake value provided); CEUS reached a correct diagnosis in 30 of these 34 cases. In 10 of 70 cases, PET was categorized as determinate but to be investigated because of discrepancy with clinical or imaging findings; CEUS a definitive diagnosis in 9 of 10 cases. CEUS proved to be effective option in the assessment of cancer patients with indeterminate PET findings.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Meios de Contraste , Aumento da Imagem/métodos , Tomografia por Emissão de Pósitrons/métodos , Ultrassonografia/métodos , Abdome/diagnóstico por imagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Vesícula Biliar/diagnóstico por imagem , Humanos , Fígado/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Baço/diagnóstico por imagem , Adulto JovemRESUMO
OBJECTIVES: Pharmacokinetic (PK) modelling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data requires a reliable measure of the arterial input function (AIF) to robustly characterise tumour vascular properties. This study compared repeatability and treatment-response effects of DCE-MRI-derived PK parameters using a population-averaged AIF and three patient-specific AIFs derived from pre-bolus MRI, DCE-MRI and dynamic contrast computed tomography (DC-CT) data. METHODS: The four approaches were compared in 13 patients with abdominal metastases. Baseline repeatability [Bland-Altman statistics; coefficient of variation (CoV)], cohort percentage change and p value (paired t test) and number of patients with significant DCE-MRI parameter change post-treatment (limits of agreement) were assessed. RESULTS: Individual AIFs were obtained for all 13 patients with pre-bolus MRI and DC-CT-derived AIFs, but only 10/13 patients had AIFs measurable from DCE-MRI data. The best CoV (7.5 %) of the transfer coefficient between blood plasma and extravascular extracellular space (K (trans)) was obtained using a population-averaged AIF. All four AIF methods detected significant treatment changes: the most significant was the DC-CT-derived AIF. The population-based AIF was similar to or better than the pre-bolus and DCE-MRI-derived AIFs. CONCLUSIONS: A population-based AIF is the recommended approach for measuring cohort and individual effects since it has the best repeatability and none of the PK parameters derived using measured AIFs demonstrated an improvement in treatment sensitivity. KEY POINTS: ⢠Pharmacokinetic modelling of DCE-MRI data requires a reliable measure of AIF. ⢠Individual MRI-DCE-derived AIFs cannot reliably be extracted from patients. ⢠All four AIF methods detected significant K (trans) changes after treatment. ⢠A population-based AIF can be recommended for measuring cohort treatment responses in trials.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Aorta/diagnóstico por imagem , Meios de Contraste/farmacocinética , Imageamento por Ressonância Magnética/métodos , Neoplasias Abdominais/irrigação sanguínea , Neoplasias Abdominais/patologia , Neoplasias Abdominais/secundário , Adulto , Idoso , Algoritmos , Antineoplásicos/uso terapêutico , Aorta/fisiopatologia , Simulação por Computador , Feminino , Humanos , Aumento da Imagem/métodos , Interpretação de Imagem Assistida por Computador/métodos , Masculino , Pessoa de Meia-Idade , Quinazolinas/uso terapêutico , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Tomografia Computadorizada por Raios XRESUMO
BACKGROUND: Patients with neuroblastoma are now stratified at diagnosis according to the presence and number of image-defined risk factors (IDRFs). We examined the added value of IDRF assessment after neoadjuvant chemotherapy for predicting surgical resection. MATERIAL AND METHODS: From 2009-2012, 39 out of 91 patients operated on in our institution for neuroblastic tumors received neoadjuvant chemotherapy based on ongoing SIOPEN protocols or treatment guidelines. IDRFs were assessed both at diagnosis and preoperatively on CT and/or MRI. RESULTS: Median age at diagnosis was 30 months [range 2-191]. The tumor locations were adrenal (n = 20), paravertebral (n = 13) and perivascular (n = 6). INRGSS stages were L2 (n = 13), M (n = 25) and Ms (n = 1). Eleven tumors (28%) were MYCN-amplified. Chemotherapy reduced the number of IDRFs in 54% of patients overall (21/39): 61.5% (16/26) of M and Ms patients, and 38.5% (5/13) of non metastatic patients (P < 0.001). The number of IDRFs lost after chemotherapy was proportional to the degree of tumor shrinkage (P = 0.002), independent of the primary tumor location (P = 0.73), although the number was higher in patients with left versus right adrenal locations (P = 0.004). Patients with neuroblastoma on post-surgical histology lost more IDRFs (median: 1[0-9]) than patients with ganglioneuroblastoma (median: 0[0-4]) (P < 0.001). The completeness of resection was related only to the number of preoperative IDRFs (P = 0.028). CONCLUSION: IDRF assessment after neoadjuvant chemotherapy is useful for predicting completeness of resection of neurogenic tumors. A larger international study is needed to confirm these results and to explore a possible correlation between preoperative IDRF status and survival.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Diagnóstico por Imagem , Imageamento por Ressonância Magnética , Terapia Neoadjuvante , Neuroblastoma/epidemiologia , Tomografia Computadorizada por Raios X , Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/tratamento farmacológico , Neoplasias Abdominais/epidemiologia , Neoplasias Abdominais/patologia , Neoplasias Abdominais/cirurgia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Carboplatina/administração & dosagem , Criança , Pré-Escolar , Terapia Combinada , Ciclofosfamida/administração & dosagem , Diagnóstico por Imagem/métodos , Etoposídeo/administração & dosagem , Feminino , Ganglioneuroblastoma/diagnóstico por imagem , Ganglioneuroblastoma/tratamento farmacológico , Ganglioneuroblastoma/epidemiologia , Ganglioneuroblastoma/patologia , Ganglioneuroblastoma/cirurgia , Transplante de Células-Tronco Hematopoéticas , Humanos , Lactente , Estimativa de Kaplan-Meier , Masculino , Estadiamento de Neoplasias , Neoplasia Residual , Neuroblastoma/diagnóstico por imagem , Neuroblastoma/tratamento farmacológico , Neuroblastoma/patologia , Neuroblastoma/cirurgia , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/prevenção & controle , Medição de Risco , Fatores de Risco , Neoplasias Torácicas/diagnóstico por imagem , Neoplasias Torácicas/tratamento farmacológico , Neoplasias Torácicas/epidemiologia , Neoplasias Torácicas/patologia , Neoplasias Torácicas/cirurgia , Resultado do Tratamento , Vincristina/administração & dosagemRESUMO
PURPOSE: Our purpose was to assess the quality of radiologic reports of CT scans performed for tumor response evaluation before and after corrective procedure. MATERIALS AND METHODS: Our objective was to assess the presence of different items in radiologic reports of CT scans performed for tumor response evaluation. The present evaluation was formal, that is to say without checking the accuracy of the items identified. Ten simple items were evaluated before and after corrective procedure corresponding to an oral and written information concerning the tumor response evaluation technique with CT. RESULTS: The results were variable depending on the items measured. Most of the criteria were improved after corrective procedure. But for some items the result remained poor or very poor as the appropriate choice of comparison review (baseline or nadir). CONCLUSION: In the absence of use of the standard form, the feedback of the quality of radiologic reports of CT scans performed for tumor response evaluation shows that the quality remains largely suboptimal even after corrective procedure.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Prontuários Médicos/normas , Neoplasias Pélvicas/diagnóstico por imagem , Terminologia como Assunto , Neoplasias Torácicas/diagnóstico por imagem , Tomografia Computadorizada por Raios X/normas , Neoplasias Abdominais/terapia , Humanos , Neoplasias Pélvicas/terapia , Neoplasias Torácicas/terapia , Fatores de TempoRESUMO
OBJECTIVES: The objective of this study was to compare image quality (objective and subjective parameters) and confidence in lesion detection between 3 image reconstruction algorithms in computed tomographic (CT) examinations of the abdomen/pelvis. MATERIALS AND METHODS: This prospective institutional review board-approved study included 65 patients (mean [SD] age, 71.3 ± 9 years; mean [SD] body mass index, 24.4 [4.8] kg) who underwent routine CT examinations of the abdomen/pelvis followed immediately by 2 low-dose scans. Raw data sets were reconstructed by using filtered back projection (FBP), adaptive statistical iterative reconstruction (ASIR), and a model-based iterative reconstruction (MBIR). Measurements of objective noise and CT numbers were compared using repeated-measures analysis of variance. Six subjective image quality parameters were scored. Diagnostic confidence and accuracy in detection of various elementary lesions were performed. RESULTS: Objectively, mean image noise for MBIR was significantly superior at all dose levels (P < 0.001). Subjectively, standard-dose ASIR and low-dose MBIR scans were better than standard-dose FBP scan in all parameters assessed (P < 0.05). Low-dose MBIR scans were comparable with standard-dose ASIR scans in all parameters except at noise index of 70 (approximately 85% dose reduction), where, in this case, the detection of liver lesions less than 5 mm were rated inferior (P < 0.05) with diagnostic accuracy reducing to 77.4%. CONCLUSIONS: Low-dose MBIR scan shows superior objective noise reduction compared with standard-dose FBP and ASIR. Subjectively, low-dose MBIR scans at 76% dose reduction were also superior compared with standard-dose FBP and ASIR. However, at dose reductions of 85%, small liver lesions may be missed.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Algoritmos , Neoplasias Pélvicas/diagnóstico por imagem , Pelve/diagnóstico por imagem , Interpretação de Imagem Radiográfica Assistida por Computador/métodos , Radiografia Abdominal/métodos , Tomografia Computadorizada por Raios X/métodos , Idoso , Idoso de 80 Anos ou mais , Simulação por Computador , Interpretação Estatística de Dados , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Modelos Estatísticos , Intensificação de Imagem Radiográfica/métodos , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeAssuntos
Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/economia , Colonografia Tomográfica Computadorizada/economia , Colonografia Tomográfica Computadorizada/mortalidade , Custos de Cuidados de Saúde/estatística & dados numéricos , Neoplasias Pélvicas/diagnóstico por imagem , Neoplasias Pélvicas/economia , Feminino , Humanos , MasculinoRESUMO
RATIONALE AND OBJECTIVES: This study summarizes the literature on the detection of cancer among indeterminate extracolonic findings on computed tomographic (CT) colonography in five targeted organs. MATERIALS AND METHODS: We searched PubMed for English-language literature published between January 1, 1994, and December 31, 2010. We describe extracolonic findings in the kidney, lung, liver, pancreas, and ovary suspect for malignancy as they are associated with high mortality. For each organ, we calculated the median prevalence, positive predictive value (PPV), and false positive rate of malignancy and a pooled false-positive rate across studies. RESULTS: Of 91 publications initially identified, 24 were eligible for review. Indeterminate renal masses on CT colonography had 20.5% median PPV and low pooled false positive rate of 1.3% (95% confidence interval 0.6-2.0). In contrast, indeterminate masses of the lung, liver, pancreas, and ovary had low PPV (median values ranged from 0% to 3.8%). Indeterminate masses of the ovary resulted in the highest pooled false-positive rate of 2.2%. Results were similar in studies of both screening and nonscreening populations. We estimated the probability of false positive results through the detection of significant extracolonic findings as 46 per 1000 for men and 68 per 1000 for women. CONCLUSIONS: Indeterminate renal masses newly detected on CT colonography have an estimated one in five chance of malignancy and therefore warrant further follow-up to provide a definitive diagnosis. Conversely, indeterminate masses of the lung, liver, pancreas, and ovary are associated with high false positive rates and merit more conservative clinical follow-up.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/economia , Colonografia Tomográfica Computadorizada/economia , Colonografia Tomográfica Computadorizada/mortalidade , Custos de Cuidados de Saúde/estatística & dados numéricos , Neoplasias Pélvicas/diagnóstico por imagem , Neoplasias Pélvicas/economia , Neoplasias Abdominais/mortalidade , Neoplasias do Colo/diagnóstico por imagem , Neoplasias do Colo/economia , Neoplasias do Colo/mortalidade , Análise Custo-Benefício , Feminino , Humanos , Incidência , Masculino , Neoplasias Pélvicas/mortalidade , Prognóstico , Medição de Risco , Taxa de SobrevidaRESUMO
OBJECTIVE: To describe the varieties and ultrasound characteristics of prenatally diagnosed fetal abdominal tumors and to scrutinize the accuracy of prenatal diagnosis as well as the postnatal outcome and therapy of affected pregnancies. STUDY DESIGN: Retrospective study of 354 fetuses found to have abdominal tumors on prenatal sonogram, identified from 1993 to 2009 at a tertiary referral center for prenatal medicine. The cohort was classified into subgroups according to the sonographic appearance of the fetal tumor and the affected anatomic structure (urinary, gastrointestinal and genital tracts and other locations). Sensitivity, specificity, positive predictive value and false-positive rate of ultrasonography in identifying the system of origin were calculated. Relationships between relevant outcome domains and the different subgroups were assessed using the chi-square test and Fisher's exact test. RESULTS: Our cohort comprised 222 urinary tract lesions, 37 genital tract lesions, 80 gastrointestinal lesions and 15 tumors of other origins. The mean gestational age at diagnosis was 26+0 wks. The prenatally established diagnosis was exactly concordant with postnatal findings in 88.9%. Sensitivity, specificity, positive predictive value and false-positive rate of ultrasonography in identifying the system of origin (urinary, gastrointestinal, genital tracts and other locations) were 98.3%, 97.6%, 92.6% and 2.4%, respectively. The favorable postnatal outcome rate was highest among fetuses with genital tract lesions (95%) and lowest among those with tumors of the urinary tract (62%, p=<0.001). Twenty per cent of tumors regressed spontaneously, mostly gastrointestinal tumors (36%, p=<0.001). In 75/354 cases (21%) the parents opted to terminate the pregnancy: intra-uterine fetal demise and neonatal death were each noted in 4%. Prenatal therapy was performed in 24 of 354 cases (7%) and postnatal surgery in 64 cases (18%). CONCLUSION: The majority of fetal abdominal anomalies were accurately diagnosed and the vast majority of affected fetuses had a favorable outcome, some tumors even resolved with advancing pregnancy. Pre- and post-natal invasive surgical interventions were mandatory in only a small number of cases.
Assuntos
Neoplasias Abdominais/embriologia , Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/fisiopatologia , Neoplasias Abdominais/terapia , Estudos de Coortes , Reações Falso-Positivas , Feminino , Seguimentos , Neoplasias Gastrointestinais/diagnóstico por imagem , Neoplasias Gastrointestinais/embriologia , Neoplasias Gastrointestinais/fisiopatologia , Neoplasias Gastrointestinais/terapia , Alemanha , Idade Gestacional , Humanos , Recém-Nascido , Masculino , Regressão Neoplásica Espontânea , Gravidez , Resultado da Gravidez , Prognóstico , Estudos Retrospectivos , Sensibilidade e Especificidade , Centros de Atenção Terciária , Ultrassonografia Pré-Natal , Neoplasias Urogenitais/diagnóstico por imagem , Neoplasias Urogenitais/embriologia , Neoplasias Urogenitais/fisiopatologia , Neoplasias Urogenitais/terapiaRESUMO
BACKGROUND: Desmoplastic small round cell tumors (DSRCT) typically have a large stromal component and often are extensively disseminated in the peritoneal cavity at diagnosis. These factors contribute to difficulty in quantifying response to chemotherapy using RECIST or WHO criteria. This study compares the overall disease response to chemotherapy by fluorodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography (CT) in patients with DSRCT. METHODS: We conducted a retrospective chart review of 7 patients with DSRCT who were imaged by FDG-PET and CT at diagnosis and after 3 cycles of chemotherapy. Response to chemotherapy was graded according to EORTC metabolic response guidelines and RECIST. RESULTS: All tumors demonstrated some decrease in SUVmax (51%±21%) and longest diameter (23%±8%) with chemotherapy. The best response achieved by FDG-PET was a partial response in 6 patients and by CT was a partial response in 1 patient. Measured response was concordant between the 2 modalities in 2 patients. CONCLUSIONS: In this small series response measurement by FDG-PET did not always correlate with response measurement by CT. A greater decrease in metabolic activity as compared with size was seen in all patients. Further studies are needed to define the role of FDG-PET in assessing early response of DSRCT to chemotherapy.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Tumor Desmoplásico de Pequenas Células Redondas/diagnóstico por imagem , Neoplasias Pélvicas/diagnóstico por imagem , Adolescente , Feminino , Fluordesoxiglucose F18 , Humanos , Masculino , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Estudos Retrospectivos , Adulto JovemRESUMO
We present a case of a 3-year-old male with history of minor trauma, who was brought in by ambulance from the playground where he had an acute mental status change and was noted to be hypotensive on initial evaluation. History and examination did not indicate a clear etiology of his symptoms. Point-of-care emergency ultrasonography revealed free fluid in the abdomen and expedited the care of the child's unexpected intra-abdominal hemorrhage from an occult abdominal tumor. This case demonstrates the ability of practitioners to expedite and focus care with the use of rapid assessment with ultrasonography in the pediatric emergency department.
Assuntos
Abdome/diagnóstico por imagem , Traumatismos Abdominais/diagnóstico por imagem , Neoplasias Abdominais/diagnóstico por imagem , Emergências , Serviço Hospitalar de Emergência , Sistemas Automatizados de Assistência Junto ao Leito , Ferimentos não Penetrantes/diagnóstico por imagem , Traumatismos Abdominais/complicações , Neoplasias Abdominais/complicações , Pré-Escolar , Diagnóstico Diferencial , Humanos , Masculino , Ultrassonografia , Ferimentos não Penetrantes/complicaçõesRESUMO
OBJECTIVES: Abdominal intensity-modulated radiation therapy and proton therapy require quantification of target and organ motion to optimize localization and treatment. Although addressed in adults, there is no available literature on this issue in pediatric patients. We assessed physiologic renal motion in pediatric patients. METHODS AND MATERIALS: Twenty free-breathing pediatric patients at a median age of 8 years (range, 2-18 years) with intra-abdominal tumors underwent computed tomography simulation and four-dimensional computed tomography acquisition (slice thickness, 3 mm). Kidneys and diaphragms were contoured during eight phases of respiration to estimate center-of-mass motion. We quantified center of kidney mass mobility vectors in three dimensions: anteroposterior (AP), mediolateral (ML), and superoinferior (SI). RESULTS: Kidney motion decreases linearly with decreasing age and height. The 95% confidence interval for the averaged minima and maxima of renal motion in children younger than 9 years was 5-9 mm in the ML direction, 4-11 mm in the AP direction, and 12-25 mm in the SI dimension for both kidneys. In children older than 9 years, the same confidence interval reveals a widening range of motion that was 5-16 mm in the ML direction, 6-17 mm in the AP direction, and 21-52 mm in the SI direction. Although not statistically significant, renal motion correlated with diaphragm motion in older patients. The correlation between diaphragm motion and body mass index was borderline (r = 0.52, p = 0.0816) in younger patients. CONCLUSIONS: Renal motion is age and height dependent. Measuring diaphragmatic motion alone does not reliably quantify pediatric renal motion. Renal motion in young children ranges from 5 to 25 mm in orientation-specific directions. The vectors of motion range from 5 to 52 mm in older children. These preliminary data represent novel analyses of pediatric intra-abdominal organ motion.
Assuntos
Neoplasias Abdominais/radioterapia , Tomografia Computadorizada Quadridimensional , Rim/diagnóstico por imagem , Movimento , Órgãos em Risco/diagnóstico por imagem , Planejamento da Radioterapia Assistida por Computador/métodos , Respiração , Neoplasias Abdominais/diagnóstico por imagem , Adolescente , Fatores Etários , Estatura , Índice de Massa Corporal , Criança , Pré-Escolar , Intervalos de Confiança , Diafragma/diagnóstico por imagem , Feminino , Humanos , Rim/anatomia & histologia , Masculino , Órgãos em Risco/anatomia & histologia , Estudos RetrospectivosRESUMO
PURPOSE: For 23 patients, an off-line positron emission tomography scan and a computed tomography scan after proton radiotherapy was performed at the Massachusetts General Hospital to assess in vivo treatment verification. A well-balanced population of patients was investigated to assess the effect of the tumor location on the accuracy of the technique. METHODS AND MATERIALS: Range verification was achieved by comparing the measured positron emission tomography activity distributions with the corresponding Monte Carlo-simulated distributions. Observed differences in the distal end of the activity distributions were analyzed as potential indicators for the range differences between the actual delivered and planned dose. RESULTS: The average spatial agreement between the measured and simulated activity distribution was within ±3 mm, and the corresponding average absolute agreement was within ±45% (derived from gamma index analysis). The mean absolute range deviation at 93 randomly chosen positions in 17 treatment fields delivered to 11 patients was 3.6 mm. Characteristic differences in the agreement of the measured and simulated activity distribution for the different tumor/target sites were found. This resulted from the different effect of factors such as biologic washout effects, motion, or limitations in the Monte Carlo-simulated activity patterns. CONCLUSION: We found that intracranial and cervical spine patients can greatly benefit from off-line positron emission tomography and computed tomography range verification. However, for the successful application of the method to patients with abdominopelvic tumors, major technological and methodologic improvements are needed. Among the intracranial and cervical spine target sites, patients with arteriovenous malformations or metal implants represent groups that could especially benefit from the approach.
Assuntos
Neoplasias/diagnóstico por imagem , Neoplasias/radioterapia , Tomografia por Emissão de Pósitrons/métodos , Terapia com Prótons , Planejamento da Radioterapia Assistida por Computador/métodos , Tomografia Computadorizada por Raios X/métodos , Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Abdominais/radioterapia , Algoritmos , Neoplasias Oculares/diagnóstico por imagem , Neoplasias Oculares/radioterapia , Neoplasias de Cabeça e Pescoço/diagnóstico por imagem , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Masculino , Método de Monte Carlo , Movimento , Neoplasias da Próstata/diagnóstico por imagem , Neoplasias da Próstata/radioterapia , Sacro , Neoplasias da Coluna Vertebral/diagnóstico por imagem , Neoplasias da Coluna Vertebral/radioterapiaRESUMO
PURPOSE: To evaluate the frequency and estimated costs of additional diagnostic workup for extracolonic findings detected at computed tomographic (CT) colonography in a large screening cohort. MATERIALS AND METHODS: This retrospective HIPAA-compliant study, which had institutional review board approval, evaluated extracolonic findings in 2195 consecutive asymptomatic adults (1199 women, 996 men; age range, 40-90 years; mean age, 58.0 years +/- 8.1 [standard deviation]) undergoing low-dose CT colonographic screening performed without contrast material at a single institution over a 20-month period. All diagnostic workups generated because of extracolonic findings were reviewed. Associated costs were estimated by using 2006 Medicare average reimbursement. Testing for statistical significance was performed by using the chi(2) and t tests. RESULTS: Further diagnostic workup for unsuspected extracolonic findings was performed in 133 (6.1%) of 2195 patients, including 18 patients in whom additional workup was not recommended by the radiologist. Additional testing included ultrasonography (n = 64), CT (n = 59), magnetic resonance imaging (n = 11), other diagnostic imaging tests (n = 19), nonsurgical invasive procedures (n = 19), and surgical procedures (n = 22). Benign findings were confirmed in the majority of cases, but relevant new diagnoses were made in 55 (2.5%) patients, including extracolonic malignancies in nine patients. The mean cost per patient for nonsurgical procedures was $31.02 (95% confidence interval: $23.72, $38.94); that for surgical procedures was $67.54 (95% confidence interval: $38.62, $101.55). CONCLUSION: Detection of relevant unsuspected extracolonic disease at CT colonographic screening is not rare, accounting for a relatively large percentage of cases in which additional workup was recommended. Judicious handling of potential extracolonic findings is warranted to balance the cost of additional workup against the potential for early detection of important disease, because many findings will prove to be of no clinical consequence.